
Pharmacoeconomic Impact of Valganciclovir Versus Valacyclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients: A Randomized Controlled Trial.
Author(s) -
Martin Kacer,
Lukáš Kielberger,
Mirko Bouda,
Tomáš Reischig
Publication year - 2014
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-201407151-02609
Subject(s) - valganciclovir , medicine , randomized controlled trial , renal transplant , cytomegalovirus , intensive care medicine , ganciclovir , transplantation , human cytomegalovirus , virology , herpesviridae , virus , viral disease